Cargando…

Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources

Alzheimer’s disease (AD) is a severe neurodegenerative disorder of different brain regions accompanied by distresses and affecting more than 25 million people in the world. This progressive brain deterioration affects the central nervous system and has negative impacts on a patient’s daily activitie...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamfu, Alfred Ngenge, Kucukaydin, Selcuk, Yeskaliyeva, Balakyz, Ozturk, Mehmet, Dinica, Rodica Mihaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472022/
https://www.ncbi.nlm.nih.gov/pubmed/34577053
http://dx.doi.org/10.3390/molecules26185582
_version_ 1784574621198057472
author Tamfu, Alfred Ngenge
Kucukaydin, Selcuk
Yeskaliyeva, Balakyz
Ozturk, Mehmet
Dinica, Rodica Mihaela
author_facet Tamfu, Alfred Ngenge
Kucukaydin, Selcuk
Yeskaliyeva, Balakyz
Ozturk, Mehmet
Dinica, Rodica Mihaela
author_sort Tamfu, Alfred Ngenge
collection PubMed
description Alzheimer’s disease (AD) is a severe neurodegenerative disorder of different brain regions accompanied by distresses and affecting more than 25 million people in the world. This progressive brain deterioration affects the central nervous system and has negative impacts on a patient’s daily activities such as memory impairment. The most important challenge concerning AD is the development of new drugs for long-term treatment or prevention, with lesser side effects and greater efficiency as cholinesterases inhibitors and the ability to remove amyloid-beta(Aβ) deposits and other related AD neuropathologies. Natural sources provide promising alternatives to synthetic cholinesterase inhibitors and many have been reported for alkaloids while neglecting other classes with potential cholinesterase inhibition. This review summarizes information about the therapeutic potential of small natural molecules from medicinal herbs, belonging to terpenoids, coumarins, and phenolic compounds, and others, which have gained special attention due to their specific modes of action and their advantages of low toxicity and high efficiency in the treatment of AD. Some show superior drug-like features in comparison to synthetic cholinesterase inhibitors. We expect that the listed phytoconstituents in this review will serve as promising tools and chemical scaffolds for the discovery of new potent therapeutic leads for the amelioration and treatment of Alzheimer’s disease.
format Online
Article
Text
id pubmed-8472022
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84720222021-09-28 Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources Tamfu, Alfred Ngenge Kucukaydin, Selcuk Yeskaliyeva, Balakyz Ozturk, Mehmet Dinica, Rodica Mihaela Molecules Review Alzheimer’s disease (AD) is a severe neurodegenerative disorder of different brain regions accompanied by distresses and affecting more than 25 million people in the world. This progressive brain deterioration affects the central nervous system and has negative impacts on a patient’s daily activities such as memory impairment. The most important challenge concerning AD is the development of new drugs for long-term treatment or prevention, with lesser side effects and greater efficiency as cholinesterases inhibitors and the ability to remove amyloid-beta(Aβ) deposits and other related AD neuropathologies. Natural sources provide promising alternatives to synthetic cholinesterase inhibitors and many have been reported for alkaloids while neglecting other classes with potential cholinesterase inhibition. This review summarizes information about the therapeutic potential of small natural molecules from medicinal herbs, belonging to terpenoids, coumarins, and phenolic compounds, and others, which have gained special attention due to their specific modes of action and their advantages of low toxicity and high efficiency in the treatment of AD. Some show superior drug-like features in comparison to synthetic cholinesterase inhibitors. We expect that the listed phytoconstituents in this review will serve as promising tools and chemical scaffolds for the discovery of new potent therapeutic leads for the amelioration and treatment of Alzheimer’s disease. MDPI 2021-09-14 /pmc/articles/PMC8472022/ /pubmed/34577053 http://dx.doi.org/10.3390/molecules26185582 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tamfu, Alfred Ngenge
Kucukaydin, Selcuk
Yeskaliyeva, Balakyz
Ozturk, Mehmet
Dinica, Rodica Mihaela
Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources
title Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources
title_full Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources
title_fullStr Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources
title_full_unstemmed Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources
title_short Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources
title_sort non-alkaloid cholinesterase inhibitory compounds from natural sources
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472022/
https://www.ncbi.nlm.nih.gov/pubmed/34577053
http://dx.doi.org/10.3390/molecules26185582
work_keys_str_mv AT tamfualfredngenge nonalkaloidcholinesteraseinhibitorycompoundsfromnaturalsources
AT kucukaydinselcuk nonalkaloidcholinesteraseinhibitorycompoundsfromnaturalsources
AT yeskaliyevabalakyz nonalkaloidcholinesteraseinhibitorycompoundsfromnaturalsources
AT ozturkmehmet nonalkaloidcholinesteraseinhibitorycompoundsfromnaturalsources
AT dinicarodicamihaela nonalkaloidcholinesteraseinhibitorycompoundsfromnaturalsources